A Continuing Education Activity Durably Addressed Knowledge Gaps Related to Penicillin Allergies Among Pharmacists and Pharmacy Technicians.
J Pharm Technol
; 38(1): 18-25, 2022 Feb.
Article
em En
| MEDLINE
| ID: mdl-35141723
ABSTRACT
Background:
Penicillin allergy is one of the most frequent self-reported allergies; however, only about 10% of reported allergies are accurate.Objectives:
Through the creation of a continuing pharmacy education (CPE) activity, we sought to assess knowledge gaps and comfort levels in the management of penicillin allergies.Methods:
A 1-hour enduring-content CPE activity was offered as an interactive course from September 20, 2019, to September 20, 2020. Participants completed 3 surveys (pre-survey, post-survey, and follow-up survey). Participants were pharmacists and pharmacy technicians who completed, at a minimum, the activity and both pre- and post-surveys. The primary outcome was the percentage of participants scoring >80% on knowledge-based questions on the post-survey compared with the pre-survey. Secondary outcomes included pre-post comparisons on knowledge-based questions, participants' self-report of an allergy, and comfort levels dispensing cephalosporins in a patient with a self-reported penicillin allergy.Results:
A total of 389 participants completed the CPE activity, with 176 included for analysis. Significantly more participants scored >80% on knowledge-based questions on the post-survey compared with the pre-survey (71.6% vs 22.7%, P < .001). There was no significant difference between the percentage of participants scoring >80% on the post-survey and the follow-up survey (71.6% vs 65%, P = .119). The majority of participants (74%) felt comfortable dispensing a cephalosporin in a patient with a penicillin allergy on the pre-survey, with similar percentages on the post- and follow-up surveys (77% and 90%, respectively).Conclusion:
A targeted continuing education program improved overall knowledge, which was sustained for up to 2 months.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
J Pharm Technol
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Estados Unidos